Breitve, Monica H. http://orcid.org/0000-0001-9042-164X
Brønnick, Kolbjørn
Chwiszczuk, Luiza J.
Hynninen, Minna J.
Aarsland, Dag
Rongve, Arvid
Funding for this research was provided by:
Wolfson Foundation
Article History
Received: 18 April 2018
Accepted: 31 July 2018
First Online: 18 August 2018
Ethics approval and consent to participate
: The study was approved by the Regional Committee for Medical and Health Research Ethics in Western Norway (REK) and the Norwegian Social Science Data Services (REK number 167.04). Patients gave written consent to participate.
: DA has received research support and/or honoraria from AstraZeneca, H. Lundbeck, Novartis Pharmaceuticals, and GE Health and has served as a paid consultant for H. Lundbeck, Eisai, and Evonik. DA is also a Royal Society Wolfson Research Merit Award holder. This study represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.